Skip to content

Author

Mark Windheim

We have 1 of 20 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Jul 2026

Adenoviral E3/49K: CD45-targeted immune evasion and therapeutic potential

The species specificity and potent immunomodulatory function of E3/49K underscore its role in adenoviral adaptation and highlight its potential for therapeutic immunosuppression and cancer therapy.

Mark Windheim, Khadija Aichane-Simon · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.